Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
What do teens and tweens want for the holidays? E-bikes, gift cards and lip tints. - 2First Alert: Light snow through this evening
- 3Exploring the Difficulties of Beginning a Family: Individual Experiences
- 4Shooting of MIT professor Nuno Loureiro has police searching for a suspect
- 5Pick Your Favored kind of soup
- Benedict Cumberbatch takes on something even Sherlock can’t solve: male grief
- 5 Critical Rules For Business Regulation Chiefs
- Surveys of 6 Hot Savvy Beds
- UN estimates over 2,000 Sudanese pregnant women have fled el-Fasher to escape conflict
- Bestselling author Colleen Hoover reveals cancer journey
- Vote in favor of your Favored kind of footwear
- What really happens when 140 reality stars come face to face with their biggest fans
- Hungary's 'water guardian' farmers fight back against desertification
- Building a Flourishing Business: Illustrations from Business people
